Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn:
“New Issue Alert: EHJ Cardiovascular Pharmacotherapy (September 2026)
This issue explores the transition from universal evidence to personalised cardiovascular pharmacotherapy, spanning trial heterogeneity, precision anticoagulation, medication adherence, drug safety, and complex pharmacokinetic challenges across diverse patient populations.
Highlights include an editorial on contextual pharmacotherapy, thought provoking discussions on inconsistency across pharmacological trials, new perspectives on extended anticoagulation for cancer associated thrombosis, machine learning approaches to statin adherence, a comprehensive review of hydroxychloroquine cardiotoxicity, and an in depth analysis of pharmacokinetics in Fontan circulation.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?